Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| unspun | 2024 | Series B | $32.0M | San Francisco |
| ZwitterCo | 2024 | Series B | $58.4M | Woburn |
| Samsara Eco | 2024 | Series A | $66.5M | Sydney |
| Atom Computing | 2024 | Venture - Series Unknown | $10.2M | Berkeley |
| Valar Labs | 2024 | Series A | $22.0M | Palo Alto |
| HelixNano | 2024 | Series A | Undisclosed | Cambridge |
| Unlearn.AI | 2024 | Series C | $50.0M | San Francisco |
| Swift Medical | 2024 | Venture - Series Unknown | $8.0M | Toronto |
| GenEdit | 2024 | Series A | $24.0M | South San Francisco |
| Totus Medicines | 2023 | Series B | $66.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | unspun | Series B | $32.0M | San Francisco, United States |
| 27 | ZwitterCo | Series B | $58.4M | Woburn, United States |
| 28 | Samsara Eco | Series A | $66.5M | Sydney, Australia |
| 29 | Atom Computing | Venture - Series Unknown | $10.2M | Berkeley, United States |
| 30 | Valar Labs | Series A | $22.0M | Palo Alto, United States |
| 31 | HelixNano | Series A | Undisclosed | Cambridge, United States |
| 32 | Unlearn.AI | Series C | $50.0M | San Francisco, United States |
| 33 | Swift Medical | Venture - Series Unknown | $8.0M | Toronto, Canada |
| 34 | GenEdit | Series A | $24.0M | South San Francisco, United States |
| 35 | Totus Medicines | Series B | $66.0M | Cambridge, United States |
Unspun is a fashion-tech company creating 3D weaving technology for apparel.
ZwitterCo provides membrane solutions for the treatment of highly-impaired wastewater.
Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
Atom Computing builds truly scalable quantum computers out of individual atoms.
Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.
Swift Medical is a digital health technology that improves the prevention, treatment, and management of wounds.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.
Fourth Power is an energy storage startup that uses thermal batteries.
Thistle Technologies is building tools that help connected device manufacturers build security resiliency into devices.
Aclarity is a VC-backed cleantech startup developing and selling water treatment systems to clean the world's water and wastewater.
Relay is a workflow automation tool with a human touch.
Citrine Informatics provides an informatics platform that transforms chemicals development through AI embedded in smart data infrastructure.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Plotlogic utilizes an AI and sensor-driven platform to enhance yield in the critical mineral industry.
Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery.
Demox Labs develops a decentralized, trustless oracle protocol for the connection of smart contracts to any off-chain data source.
Honeycomb provides full-stack observability for engineering teams to understand, debug, and improve production systems.
Horizon Quantum Computing builds software development tools to code, compile and deploy quantum applications from classical code.
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Recycleye is a developer of digital tools designed to detect and provide analytics on waste management.
DCVC has invested in 212 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC's top investment sectors include Artificial Intelligence (AI), Health Care, Biotechnology, Software, Medical. The firm invests across 53 different industry categories.
Among tracked funding rounds, Samsara Eco received $66.5M in a Series A round. DCVC's total known invested capital is $3.0B.
DCVC's average investment size is $23.8M across its portfolio of 212 companies.
Recent DCVC portfolio additions include unspun, ZwitterCo, Samsara Eco, Atom Computing, Valar Labs. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors